Global Niraparib Market Set for Strong Growth Amid Rising Demand for Targeted Cancer Therapies Read More => https://dataintelo.com/report/niraparib-market The Niraparib Market is poised for substantial growth, driven by increasing adoption of targeted cancer treatments worldwide. Niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has transformed ovarian cancer therapy and shows promise across other solid tumors. As personalized medicine advances, demand for effective therapies like Niraparib continues to rise globally.